Search Results
Nov 10, 2025, 08:00 ET Cellex Symposium 2025 Brings Together International Experts to Discuss the Evolving Field of Cell and Gene Therapy
About Cellex Cell Professionals GmbH Cellex Cell Professionals is a leading, full service CDMO specializing in CGT. With its state-of-the-art facilities located in Cologne, Germany, and a proven track record of 10+ years in GMP-compliant autologous
More news about: Cellex Cell Professionals
Nov 10, 2025, 08:00 ET Cellex Symposium 2025: debate sobre el campo en evolución de la terapia celular y génica
Acerca de Cellex Cell Professionals GmbH Cellex Cell Professionals Cellex es una CDMO líder de servicio completo especializada en terapias celulares génicas (TCG). Con instalaciones de vanguardia en Colonia, Alemania, y una trayectoria
More news about: Cellex Cell Professionals
Nov 07, 2025, 06:09 ET Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses
during the quarter, taking its portfolio to 32 own commercial products, 81 approved ANDAs, and 70 pipeline products, alongside 32 commercial CDMO/CMO products and 45 in the pipeline. Emerging Markets: The company's
More news about: Senores Pharmaceuticals Limited
Nov 06, 2025, 04:46 ET WuXi XDC Named the Winner of "Best CDMO" and "Best CRO" at 2025 World ADC Awards
Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced that it has been named the winner of "Best CDMO" for the third consecutive year and the winner of "Best CRO" at 2025 World ADC Awards. In this year's World ADC Awards, WuXi XDC was the only service
More news about: WuXi XDC
Nov 06, 2025, 03:00 ET Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development Solution
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human antibodies, announced
More news about: Abzena
Nov 05, 2025, 12:57 ET Piramal Pharma Limited Announces Results for Q2 and H1 FY26
CDMO
More news about: Piramal Pharma Limited
Nov 05, 2025, 10:31 ET Hyaluronic Acid Products Market to Reach $20 billion, Globally, by 2034 at 7.7% CAGR: Allied Market Research
contract development and manufacturing organization ('CDMO'), announced that it has finalized a series of updated commercial arrangements with its long-term commercial Hyaluronic Acid and CDMO customer, Alcon to extend and expand the existing CDMO relationship. In addition, it also entered into a limited
More news about: Allied Market Research
Nov 05, 2025, 08:00 ET IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
capabilities covering vaccines, gene and immune therapeutics Strengthening global CDMO strategy through strategic synergy with SK bioscience Sustainable growth expected,
More news about: SK bioscience
Nov 05, 2025, 08:00 ET BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
Dr. Ziye Sui, Executive Director and CEO of Lepu BioPharma, commented: "We sincerely thank the BioDlink team for their outstanding CDMO services and strong collaboration. This approval also establishes a practical pathway for multi-party collaboration, offering new hope for R/M NPC patients
More news about: BioDlink Biopharm Co., Ltd.
Nov 04, 2025, 04:00 ET Elevaris 於歐洲、中東與非洲地區推出 CDMO 服務及手術針具產品組合
Devices 簡介： Elevaris Medical Devices 是業界領先的跨國醫療保健公司、醫療設備製造商和新興科技公司的合約開發和製造組織 (CDMO)。該公司是全球領先訂製手術針製造商之一，專門製造精密微型組件、複雜管狀組件和子組件。公司還分銷各種輔助藥品、手術儀器和醫療用品。 Elevaris Medical Devices 在北美、英國和韓國各地擁有 300 多名員工。更多資訊，請瀏覽 elevarismedical.com。
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevaris führt CDMO-Dienstleistungen und ein Portfolio von Verfahrensnadeln in EMEA ein
zusammengebracht, und wir sind begeistert, diese Angebote auf Europas größter Bühne für Medizinproduktehersteller vorzustellen." Als CDMO bietet Elevaris umfassende Fertigungsspezialitäten, um Herstellern von Medizinprodukten weltweit Präzisionslösungen zu bieten. Das Unternehmen fertigt
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA
Medical Devices, "and we're thrilled to introduce these offerings on Europe's largest stage for medical device manufacturers. As a CDMO, Elevaris offers extensive manufacturing specialties to help medical device manufacturers worldwide deliver precision solutions. The company manufactures
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA
Medical Devices, "and we're thrilled to introduce these offerings on Europe's largest stage for medical device manufacturers. As a CDMO, Elevaris offers extensive manufacturing specialties to help medical device manufacturers worldwide deliver precision solutions. The company manufactures
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevaris presenta sus servicios de CDMO y su gama de agujas para procedimientos en EMEA
europeo para fabricantes de dispositivos médicos" declaró Richard Zrebiec, consejero delegado de Elevaris Medical Devices. Como CDMO (Organización de Desarrollo y Fabricación por Contrato), Elevaris ofrece una amplia gama de especialidades de fabricación para ayudar a los fabricantes
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET A Elevaris apresenta serviços de CDMO, portfólio de agulhas processuais para a EMEA
"e estamos entusiasmados em apresentar essas ofertas no maior palco da Europa para fabricantes de dispositivos médicos. Como CDMO, a Elevaris oferece amplas especialidades de fabricação para ajudar os fabricantes de dispositivos médicos em todo o mundo a fornecer soluções de precisão.
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevaris introduit des services CDMO et une gamme d'aiguilles de procédure dans la région EMEA
sommes ravis de présenter ces offres sur la plus grande scène d'Europe pour les fabricants de dispositifs médicaux. En tant que CDMO, Elevaris offre des spécialités de fabrication étendues pour aider les fabricants de dispositifs médicaux du monde entier à fournir des solutions de
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET Elevarispresenta los servicios CDMO y la cartera de agujas de procedimiento en EMEA
estamos encantados de presentar estas ofertas en el escenario más grande de Europa para fabricantes de dispositivos médicos. Como CDMO, Elevaris ofrece amplias especialidades de fabricación para ayudar a los fabricantes de dispositivos médicos de todo el mundo a ofrecer soluciones de
More news about: Elevaris Medical Devices Inc.
Nov 04, 2025, 04:00 ET 엘레바리스, EMEA 지역에 CDMO 서비스와 시술용 바늘 제품군 첫선
More news about: Elevaris Medical Devices Inc.
Nov 03, 2025, 08:00 ET Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND
STATION, Texas, Nov. 3, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership with Calidi Biotherapeutics, Inc. ("Calidi"), a clinical-stage immuno-oncology
More news about: Matica Biotechnology, Inc.
Nov 03, 2025, 08:00 ET OFD Life Sciences Bolsters Quality and R&D Leadership Amid Growing Demand for Biotech Innovation
Oregon Freeze Dry, one of the largest and most technologically advanced freeze-dryers in North America. OFD Life Sciences is a specialized CDMO focused on providing solutions to biopharma, consumer health, and animal health companies through its deep expertise in lyophilization. Featuring LyoLock™
More news about: OFD Life Sciences
Nov 03, 2025, 08:00 ET Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
About ABLAdvanced BioScience Laboratories (ABL) is a contract development and manufacturing organization (CDMO) dedicated to advancing therapeutics, vaccines, and other biological products. With over 60 years of experience working with diverse organizations including
More news about: Ginkgo Bioworks
Nov 03, 2025, 07:00 ET Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO
Proposal approved in shareholders' meeting with 99.9% support Company to reaffirm its identity as a pure-play CDMO INCHEON, South Korea, Nov.
More news about: Samsung Biologics
Nov 03, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
CellReady LLC CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support
More news about: Bio-Techne Corporation
Oct 31, 2025, 08:00 ET Elevaris Medical Devices 任命新任首席工程兼營運總監
Devices 簡介： Elevaris Medical Devices 是業界領先的跨國醫療保健公司、醫療設備製造商和新興科技公司的合約開發和製造組織 (CDMO)。該公司是全球領先訂製手術針製造商之一，專門製造精密微型組件、複雜管狀組件和子組件。公司還分銷各種輔助藥品、手術儀器和醫療用品。 Elevaris Medical Devices 在北美、英國和韓國各地擁有 300 多名員工。如欲更多資料，請瀏覽 elevarismedical.com。
More news about: Elevaris Medical Devices Inc.
Oct 31, 2025, 08:00 ET Elevaris Medical Devices Names New Chief Engineering and Operations Officer
About Elevaris Medical Devices: Elevaris Medical Devices is a Contract Development and Manufacturing Organization (CDMO) for industry-leading multi-national healthcare companies, medical device manufacturers, and emerging technology companies. It is one of the world's
More news about: Elevaris Medical Devices Inc.